Home / Posts Tagged "COVID-19" (Page 13)

Cheap antidepressant shows promise against COVID-19 Fluvoxamine, an inexpensive antidepressant, might help keep patients with COVID-19 from developing severe disease, according to a new study published in The Lancet Global Health on Wednesday. Researchers in Brazil recruited nearly 1,500 COVID-19 patients at high risk for complications

READ MORE

Bharat Biotech's Covaxin has been included to the approved list of COVID-19 vaccines for travel to Oman without Quarantine. In a tweet, Bharat Biotech noted: "Covaxin has now been added to the approved list of #COVID 19 vaccines for travel to Oman without quarantine. This will

READ MORE

A widely available antidepressant holds promise as a treatment for Covid-19, according to a new study. Covid-19 patients who received fluvoxamine were significantly less likely to require hospitalization than those who didn’t, in the largest clinical trial evaluating the antidepressant’s effect on Covid-19 to date. Fluvoxamine

READ MORE

The test positivity rate of Covid-19 in Delhi touched 0.08% on Tuesday, the highest in 22 Days. The daily cases also rose to 41. This is the maximum daily cases also rose to 41. This is the maximum daily cases recorded in the national capital

READ MORE

Simultaneously detects HCV core antigen and anti-HCV antibodies for more accurate screening Reduces window period to less than 28 days, resulting in earlier diagnosis Next-gen testing solution suitable for blood banks Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company, committed to a Healthier India,

READ MORE

Mr. Sudarshan Jain took over as the Chairperson of IIHMR University, Jaipur, a renowned post-graduate research University. The University a pioneer higher education institution in the country dedicated to the improvement in standards of health through better management of healthcare and related programme through management

READ MORE

On Monday, Moderna Inc (MRNA.O) said its COVID-19 vaccine which generated a strong immune response in children aged six to 11 years and that it plans to submit the data to global regulators soon. Moderna said its two-dose vaccine generated virus-neutralizing antibodies in children and

READ MORE

Vaccines for kids between the ages of 5 and 11 will likely be available in the first half of November, top U.S. infectious disease expert Anthony Fauci said on Sunday, predicting a timetable that could see many kids getting fully vaccinated before the end of

READ MORE

Two studies in major medical journals add to evidence that COVID-19 vaccines are safe before and during pregnancy. One study, published in The New England Journal of Medicine on Wednesday, tracked nearly 18,500 pregnant women in Norway, including about 4,500 who had miscarriages. Researchers found

READ MORE